Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) shares rose 8.8% during trading on Wednesday . The stock traded as high as $23.51 and last traded at $23.44. Approximately 139,605 shares were traded during trading, a decline of 42% from the average daily volume of 241,645 shares. The stock had previously closed at $21.55. Analyst […]
Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report)’s share price fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $21.90 and last traded at $22.12. 111,875 shares traded hands during mid-day trading, a decline of 54% from the average session volume of 240,997 shares. The stock had previously closed at […]
Recent health news includes drugmaker WuXi AppTec working with Chinese military scientists on altitude sickness treatments, FDA halting Biomea's diabetes trials due to liver toxicity, and a bird flu outbreak in Minnesota. Additionally, an antitrust probe into pharmaceutical companies over an eye drug and Novo Nordisk facing generic challenges in China are reported.
For several months, a U.S. security crackdown on biopharma firms suspected to be linked to the Chinese Communist Party (CCP) has continued to gain steam.
The U.S. House of Representatives
committee on China has asked the FBI and the intelligence
community for a briefing on GenScript Biotechnology Co
and three subsidiaries to determine if the Chinese.